These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16540155)

  • 1. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.
    Markman M
    Gynecol Oncol; 2006 Jun; 101(3):550-1; author reply 551-2. PubMed ID: 16540155
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.
    Bristow RE; Giuntoli RL; Pannu HK; Schulick RD; Fishman EK; Wahl RL
    Gynecol Oncol; 2005 Nov; 99(2):294-300. PubMed ID: 16051330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review.
    Makhija S; Howden N; Edwards R; Kelley J; Townsend DW; Meltzer CC
    Gynecol Oncol; 2002 Apr; 85(1):53-8. PubMed ID: 11925120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac.
    Díaz-Montes TP; Jacene HA; Wahl RL; Bristow RE
    Gynecol Oncol; 2005 Sep; 98(3):510-2. PubMed ID: 15992914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of PET-CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data Collection Project.
    Markman M
    Gynecol Oncol; 2009 Sep; 114(3):536; author reply 536-7. PubMed ID: 19482342
    [No Abstract]   [Full Text] [Related]  

  • 7. Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer.
    Barranger E; Kerrou K; Petegnief Y; David-Montefiore E; Cortez A; Daraï E
    Gynecol Oncol; 2005 Jan; 96(1):241-4. PubMed ID: 15589609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report.
    Yuan CC; Liu RS; Wang PH; Ng HT; Yeh SH
    J Reprod Med; 1999 Sep; 44(9):775-8. PubMed ID: 10509300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.
    Pan HS; Lee SL; Huang LW; Chen YK
    Arch Gynecol Obstet; 2011 Feb; 283(2):335-41. PubMed ID: 20221620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of PET/CT in the management of recurrent ovarian cancer.
    Simcock B; Neesham D; Quinn M; Drummond E; Milner A; Hicks RJ
    Gynecol Oncol; 2006 Oct; 103(1):271-6. PubMed ID: 16626793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
    Thrall MM; DeLoia JA; Gallion H; Avril N
    Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of positron emission tomography in diagnosis of recurrent ovarian cancer].
    Ding XL; Shen K; Lang JH; Wu M; Huang HF; Pan LY; Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):667-9. PubMed ID: 14728852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
    Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer.
    Cho SM; Ha HK; Byun JY; Lee JM; Kim CJ; Nam-Koong SE; Lee JM
    AJR Am J Roentgenol; 2002 Aug; 179(2):391-5. PubMed ID: 12130439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET for management of cervical and ovarian cancer.
    Havrilesky LJ; Kulasingam SL; Matchar DB; Myers ER
    Gynecol Oncol; 2005 Apr; 97(1):183-91. PubMed ID: 15790456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The accuracy of CT and tumor markers in the detection of a recurrent ovarian carcinoma].
    Wakabayashi Y; Ishida J; Kotake F; Hirose M; Kawana K; Abe K; Amino S; Negishi Y; Akiya K
    Gan No Rinsho; 1989 Sep; 35(10):1127-31. PubMed ID: 2550684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer.
    Hauth EA; Antoch G; Stattaus J; Kuehl H; Veit P; Bockisch A; Kimmig R; Forsting M
    Eur J Radiol; 2005 Nov; 56(2):263-8. PubMed ID: 16233894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.
    Nanni C; Rubello D; Farsad M; De Iaco P; Sansovini M; Erba P; Rampin L; Mariani G; Fanti S
    Eur J Surg Oncol; 2005 Sep; 31(7):792-7. PubMed ID: 15893908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of positron emission tomography/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis.
    Limei Z; Yong C; Yan X; Shuai T; Jiangyan X; Zhiqing L
    Int J Gynecol Cancer; 2013 May; 23(4):598-607. PubMed ID: 23502451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
    Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.